2025-10-13 – Press Releases – www.prnewswire.com
TAIPEI, Oct. 13, 2025 /PRNewswire/ — AnnJi Pharmaceutical Co., Ltd. (AnnJi, TWSE: 7754) announced that the Phase 2a clinical result of AJ201 for spinal and bulbar muscular atrophy (SBMA, also known as Kennedy’s disease) was selected as one of the seven Late-Breaking Abstracts at the…
